Livzon Pharmaceutical Group Inc.
SZSE:000513.SZ
Overview | Financials
Company Name | Livzon Pharmaceutical Group Inc. |
Symbol | 000513.SZ |
Currency | CNY |
Price | 32.51 |
Market Cap | 26,631,898,630 |
Dividend Yield | 3.97% |
52-week-range | 31.72 - 40.67 |
Industry | Drug Manufacturers—Specialty & Generic |
Sector | Healthcare |
CEO | Mr. Yanggang Tang |
Website | https://www.livzon.com.cn |
An error occurred while fetching data.
About Livzon Pharmaceutical Group Inc.
Livzon Pharmaceutical Group Inc. engages in the research, development, production, and sale of pharmaceutical products, and active pharmaceutical ingredients and intermediates in the People's Republic of China. The company offers Ilaprazole enteric coated tablets for the treatment of duodenal ulcers and reflux esophagitis; Laprazole sodium for injection to treat peptic
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD